CTRI/2022/05/042393已完成2 期
A Randomized, Multi-center, Prospective, Comparative Clinical Study to evaluate efficacy and safety of AP/VJT/SBO Ayurvedic Hair Oil in mild to moderate Hair loss in females - NI
AYURVED PRATISTHA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects suffering from mild to moderate hair loss (40-140 Hair by Comb test and Finger Test).
- •2.Subjects who are infrequent hair oil users
- •3.Subjects who are willing to give informed consent and ready to comply with the protocol
- •4.Subjects who are ready to provide regular follow ups till the completion of the study.
排除标准
- •1.Subjects with severe Hair fall due to any clinically significant disorder/s like anemia, thyroid disorders etc.
- •2.Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation
- •3.Subjects with recent disease history like, malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study
- •4.Subjects who have regularly used anti-hair fall treatment with hair oils over the last 6 months.
- •5.Subjects who have previously undergone hair transplantation procedures
- •6.Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
- •7.Subjects on immunosuppressive drugs
- •8.Known cases of Hypersensitivity to hair oil contents
- •9.Subjects who have participated in any other clinical study since last 3 months
- •10.Subjects who are reported pregnant/planning a pregnancy or lactating.
- •11.Menopausal Women
研究者
相似试验
尚未招募
不适用
A Multi-center, Prospective, Randomized Comparison of Pulmonary Vein Isolation Techniques in Patients with Paroxysmal Atrial FibrillatioDiseases of the circulatory systemKCT0000329Asan Medical Center100
进行中(未招募)
3 期
A clinical research to study the safety, efficacy and immunogenicity of test pertuzumab in metastatic breast cancer patients.CTRI/2023/05/052997Enzene Biosciences Limited
已完成
3 期
Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)CTRI/2022/03/041271Zydus Research Centre Cadila Healthcare Limited268
已完成
3 期
Safety and efficacy Assessment of Trastuzumab emtansine of Cadila Healthcare Ltd in comparison with Reference drug(Trastuzumab emtansine) for the treatment of metastatic breast cancerCTRI/2018/07/014881Cadila Healthcare Ltd168
已完成
3 期
A Clinical Study to Test the Effectiveness and Side Effects of Hetero-Tenecteplase in Adult patients with Suspected Myocardial InfarctioCTRI/2021/06/034322Hetero Biopharma Limited198
